Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 1, 2010, Pages 134-135

  Brinkmann, F ^a   Schwerk, N ^b   Hansen, G ^b   Ballmann, M ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Allergic bronchopulmonary aspergillosis; Cystic fibrosis; Pneumonology

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E; ITRACONAZOLE; OMALIZUMAB; PREDNISOLONE; VORICONAZOLE;

ADOLESCENT; ARTICLE; ASPERGILLOMA; ASPERGILLUS FUMIGATUS; CASE REPORT; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE MARKER; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; FEMALE; FORCED EXPIRATORY VOLUME; GROWTH RETARDATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION; LUNG INFILTRATE; PRIORITY JOURNAL; TREATMENT OUTCOME; WHEEZING;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; CYSTIC FIBROSIS; HUMANS; RESPIRATORY FUNCTION TESTS;

EID: 72049122135     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02147.x     Document Type: Article

References (6)

1. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Participants in the Cystic Fibrosis Foundation Consensus Conference et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis - state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37(Suppl. 3): S225-S264.
2. Wark PA, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2004;3:CD001108.
3. van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007;62:276-277. (Pubitemid 46579813)
4. Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008;43:1249-1251.
5. Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008;43:607-610.
6. Hilliard T, Edwards S, Buchdahl R et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros. 2005;4:215-220; Epub. 20 Oct 2005. (Pubitemid 43013027)